SCHEMBL20832592

SCHEMBL20832592

CC(C)C(=O)Nc1nccc(C(O)CCl)n1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 3/20 0.40
▸ CDC7 O00311 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.37
▸ LMNA P02545 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ ADORA2A P29274 3/20 0.36
▸ TYK2 P29597 1/20 0.36
▸ MAP4K1 Q92918 1/20 0.36
▸ FFAR2 O15552 1/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ HSD17B10 Q99714 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20832591 1.00 ADORA1 (0.40) ADORA1CDC7ALDH1A1LMNAHTT
SCHEMBL28891555 0.83 ADORA1 (0.45) ADORA1CDC7ALDH1A1LMNAHTT
SCHEMBL28891554 0.83 ADORA1 (0.45) ADORA1CDC7ALDH1A1LMNAHTT
SCHEMBL15358651 0.80 ADORA1 (0.45) ADORA1CDC7ALDH1A1LMNAHTT
Hydrochloric Acid SCHEMBL15350011 0.79 ADORA1 (0.44) ADORA1CDC7ALDH1A1LMNAHTT
SCHEMBL20832590 0.75 CDC7 (0.44) ADORA1CDC7ALDH1A1LMNAHTT
SCHEMBL19699460 0.73 L3MBTL1 (0.51) ADORA1CDC7LMNANPC1RAB9A
SCHEMBL22186399 0.71 KDM4E (0.65) ADORA1CDC7ALDH1A1LMNAHTT
SCHEMBL23015811 0.69 KDM4E (0.43) ADORA1CDC7LMNANPC1RAB9A
SCHEMBL23015805 0.69 KIF11 (0.40) CDC7FFAR2NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111315726-A Heteroaryl substituted β -hydroxyethylamines for the treatment of hyperglycemia 阿托基公司 2020-06-19 — — CN disclosed
WO-2019053427-A1 HETEROARYL SUBSTITUTED BETA-HYDROXYETHYLAMINES FOR USE IN TREATING HYPERGLYCAEMIA ATROGI AB (SE) 2019-03-21 — — WO disclosed
Send feedback